Whatever the demands of international regulators, it is public expectations that will ultimately dictate the need for life sciences companies to prepare complete and accurate product data that patients and healthcare providers can scrutinize on demand.
The revolution in data and technology should be pushing companies to focus on safeguarding intellectual property.
How are you protecting your IP and keeping talent from going overseas?
Within this large and growing market, some companies are capitalizing, while others are faltering.
There are several steps you can take to protect your IP and avoid medical device piracy in China.